Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

L.A. McKeown

July 10, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Daily News

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

Todd Neale

March 06, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Genes May Help Explain Link Between Adverse Pregnancy Outcomes, Later CVD

Caitlin E. Cox

January 21, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

Advertisement

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

No Clear Risk of Dementia After TIA: Framingham Heart Study

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

FDA Approves Triple Therapy Polypill for High Blood Pressure

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

DOACs Reduce Stroke, Increase Bleeding in ICH Survivors With AF

ACC/AHA Release New Comprehensive ACS Guidelines

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Aspirin Use for Primary Prevention Declining in US: NHANES

Genes May Help Explain Link Between Adverse Pregnancy Outcomes, Later CVD

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content